Pfizer announced this week that it had launched the final phase of testing for an experimental vaccine to prevent Lyme disease in people 5 years old and above.
Pfizer and its French partner Valneva, will enroll about 6,000 volunteers, ages 5 and up for the late-stage clinical trial that will test the vaccine, VLA15, against the tick-borne illness, according to a press release.
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
You can unsubscribe any time. By subscribing you agree to our Terms of Use
The Defender reports: The company plans to create a seasonal vaccine that people age 5 and older can get during the months when ticks are most active.
If approved, the vaccine could be the first human vaccine available for Lyme disease in the U.S. in more than two decades after LYMERix, manufactured by GlaxoSmithKline, was withdrawn from the market in 2002, due to lawsuits, safety concerns and dwindling sales.
According to a press release, Pfizer and French partner Valneva are enlisting 6,000 participants ages 5 and older for a late-stage clinical trial that will test the vaccine, VLA15, against the tick-borne illness.
According to ClinicalTrials.gov, “18,000 healthy participants 5 years and older” were recruited for the study. In its press release, Pfizer did not explain the discrepancy in the number of trial participants.
VLA15 is a “multivalent protein subunit vaccine” targeting “the outer surface protein A (OspA) of Borrelia,” the bacteria that causes Lyme disease. The vaccine is supposed to protect against six forms of the protein expressed by the bacterial species present in North America and Europe.
During the Phase 3 clinical trial, participants will receive three doses of VLA15 or a placebo, followed by one booster dose or another placebo, The Washington Post reported.
The study will be held in as many as 50 sites where Lyme disease is “highly endemic,” the drugmakers said, including Finland, Germany, the Netherlands, Poland, Sweden and the U.S.
Pending successful completion of the trials, Pfizer may request approval for its vaccine from regulators in the U.S. and Europe in 2025.
Niamh Harris
Latest posts by Niamh Harris (see all)
- Archbishop Vigano: We Are Undergoing A Global Coup D’état & Must Fight Back Or Lose Everything - November 28, 2023
- Elon Musk Supports Israel’s Assault On Gaza - November 28, 2023
- Hungary’s PM Viktor Orban Warns West That Russia ‘Will Not Lose’ - November 28, 2023
In the next 5 years the CDC vaccine schedule will have about 150 shots by the time you’re 5 years old.
Yes agreed and they will be working in developing more and more types that need annual top ups for the term of victims natural lives.
Lyme Disease, developed by the United States Army at Fort Detrick in the 1980s as a biological warfare weapon.
Another “Vaccine” from what he Wise would stay 10 miles away.
Absolutely Where the SCIENTISTS earn big bucks to create deadly diseases to kill cheaply and neatly and let the government’s and industrialists, the wealthy look innocent
Naturally science created it and all the research centres in all the regional arenas were sent their infected tics to distribute .
Who’s going to trust any vaccine with all the deaths caused by the mandatory fauci covid vaccine?
Only those who are low IQ and still deceived. Revelation 18:23: “…for by thy sorceries (pharmakia is the word in the original Greek text) were all nations deceived.” God told us over 2000 yrs ago.
MORE BIOWEAPONS DRILL SARGENT MORE BIOWEAPONS
Does phizer have a vaccine for gullibility?